QuantumCURE Pro – Citizen-Driven, Quantum-Enhanced Drug Discovery

Update: April-May 2026

​

​

​

 

 

 

 

 

 

 

 

Built in Oklahoma City. Designed for real drug-discovery work.

I’m Mansour Ansari, founder of QuantumLaso, LLC. From my back office in Oklahoma City, I’ve been building QuantumCURE Pro™ as a full-stack docking and scoring platform for serious early-stage drug discovery. My goal has never been to build another generic interface on top of a docking engine. My goal has been to build a practical discovery factory: one that combines cloud-scale molecular docking, structured scoring, compound triage, and a new layer of quantum-aware exploration using QRNG hardware, annealing-derived seeds, and symbolic pattern tracking.

​

QuantumCURE Pro™ is designed for independent researchers, small labs, startup teams, and citizen scientists who want more than a simple “upload and score” tool. It is built for users who want a structured path from protein preparation to shortlist construction, from shortlist to wet-list formation, and from there toward lab-ready decision support. The platform does not stop at ranking compounds. It is designed to help explain why a compound deserves attention, what conditions produced it, and how it fits into a broader discovery pipeline.

 

This page outlines what QuantumCURE Pro™ does today, how the system is structured under the hood, and where the roadmap is heading next.

What QuantumCURE Pro™ Is

QuantumCURE Pro™ is a cloud-enabled docking and scoring system built around a disciplined end-to-end workflow:

• protein preparation

• ligand intake and normalization

• docking execution

• scoring and structural analysis

• shortlist construction

• wet-list development

• future AI and validation layers

At its core, the platform is meant to make early-stage compound exploration more structured, more explainable, and more accessible without lowering the seriousness of the science. The aim is not just to produce docking scores. The aim is to build a usable discovery engine that can scale across large ligand campaigns while preserving traceability, entropy provenance, and post-docking interpretability.

System Overview

1. Protein Preparation

QuantumCURE Pro™ begins with protein preparation at scale. Protein structures can be fetched or imported, cleaned, corrected, and converted into reusable, prepared targets. This includes the removal of irrelevant crystallographic artifacts where appropriate, the addition of hydrogens, the assignment of charges, the handling of structural irregularities, and the storage of reusable docking grids or binding-site bundles. The design philosophy is to prepare proteins once, preserve that preparation state, and then reuse it across many ligand campaigns.

This separation matters because it decouples target preparation from ligand throughput. The heavy setup work can be done once, then reused across repeated docking campaigns, allowing the docking layer to operate much more efficiently.

2. Ligand Intake and Normalization

Ligands can be drawn from sources such as PubChem, ChEMBL, or curated custom libraries. Once selected, they move through a normalization and preparation stage that includes structure cleanup, SMILES handling, conformer generation, and filtering by practical criteria such as molecular-weight windows, chemistry flags, or other campaign constraints. The system is designed to track what has already been prepared and processed so that compute is not wasted repeating the same preparation work unnecessarily.

This intake layer is becoming more intelligent over time. New batch-governance features now help assess compounds before docking begins, allowing the user to review operational risk, refine the batch, and avoid wasting runtime on obviously problematic selections.

3. Docking Execution

Docking is executed through a cloud-oriented worker architecture designed to support large ligand campaigns. The platform uses classical docking workflows for baseline exploration and reproducible search behavior, while also supporting quantum-enhanced exploration modes through QRNG-driven entropy and annealing-derived seed strategies. The goal is not to replace classical docking, but to extend how the platform explores search space and tracks which entropy source contributed to which discovery path.

Every run is part of a broader result model that captures affinities, metadata, entropy provenance, and downstream analysis outputs rather than merely returning a bare docking score.

4. Scoring and Structural Forensics

QuantumCURE Pro™ adds multiple post-docking interpretation layers on top of raw docking output. These include energy-style binding scores, predicted IC₅₀ modeling, van der Waals clash analysis, scaffold grouping, and dose-response style outputs for shortlisted compounds. The intent here is to move beyond “dock and forget.” The system is built to support compound triage and explainability, not just sorted score tables.

This means promising compounds can be reviewed not only for their score, but also for structural plausibility, scaffold context, and eventual wet-list value.

5. Wet List and Golden List Workflow

The long-term objective of the platform is a defensible wet-list pipeline. Large numbers of compounds can be run across different entropy modes, filtered through scoring and structural logic, then reduced into a much smaller shortlist for further review. That shortlist can later be passed into additional AI, validation, and electron-distribution workflows. The strongest survivors form what I call the Golden List: compounds that have survived docking, entropy-aware filtering, and deeper layers of downstream review.

This is one of the core philosophical differences in how I designed the system. The endpoint is not a pretty dashboard. The endpoint is a more defensible path toward real compounds worth testing.

Under the Hood

Core Pipeline

QuantumCURE Pro™ currently centers around these core architectural layers:

• protein preparation engine

• ligand preparation and conformer generation

• cloud-ready docking workers

• result storage and replay structures

• exportable analysis outputs for downstream review and AI workflows

The platform is being designed so that heavy preparation work, large-scale execution, and downstream interpretation can all coexist in a single organized system rather than as disconnected scripts or manual workflows.

Entropy Sources

QuantumCURE Pro™ supports multiple entropy paths, each with a different purpose:

• PRNG for reproducible classical baselines and debugging

• QRNG for quantum-derived entropy from real physical events

• Annealing-derived seeds harvested from D-Wave QUBO workflows

• future expansion toward additional hardware entropy sources

This allows the platform not only to run compounds, but to record which entropy source participated in a given search path. Over time, that creates a richer discovery record and supports entropy-aware lead discovery workflows.

Data and Output Layers

Outputs may include:

• docking scores and associated metadata

• entropy source annotations

• IC₅₀-related estimates

• scaffold clustering context

• structural forensics signals

• wet-list export structures

• JSON-ready output for future AI and ML analysis

The system is designed so results can be replayed, inspected, filtered, and later enriched by more advanced tooling.

New Batch Intelligence Features

One of the most important developments in QuantumCURE Pro™ is the move toward pre-docking batch intelligence. Instead of waiting until the run is finished to discover that compounds were poor operational candidates, the system now supports a growing set of controls before the docking engine begins.

Pre-Dock Forecast

The platform can assess a batch before launch and estimate operational risk, including likely chemistry-preparation issues, likely timeout behavior, and mixed-risk conditions. This is not a prediction of final scientific success. It is a practical forecast of what may happen operationally under the current profile and settings.

Iterative Batch Refinement

If risky compounds are detected before launch, the user can selectively replace them from the same source bucket and re-run the assessment. This allows the batch to be improved before compute is spent.

Outcome Intelligence

The post-run experience has also been strengthened so that full success, partial success, chemistry quarantine, timeout-limited batches, worker failures, and cancelled runs are clearly separated rather than blended together.

Duplicate and Reservation Awareness

The platform is also moving toward a formal dedupe and reservation layer so that random selection from very large buckets does not keep re-processing the same compounds under the same conditions, especially as multi-user workflows expand.

These additions are important because they move the product from a simple docking front end toward a much more disciplined batch-governance system.

Current Technical Focus

The current product direction focuses on making QuantumCURE Pro™ more intelligent, more reliable, and more scalable before a wider multi-user release. That includes:

• stronger pre-launch batch screening

• smarter compound refinement before queueing

• clearer post-run truth handling

• dedupe and reservation logic for large shared buckets

• more robust multi-user plumbing

• stronger wet-list and Golden List governance

• cleaner review and export workflows

In other words, the platform is being hardened not only as a docking engine but as a controlled research environment.

Roadmap

Near-Term Roadmap

The next stage of QuantumCURE Pro™ is focused on product hardening and workflow maturity:

• multi-user infrastructure

• reservation and dedupe enforcement

• stronger batch-level auditability

• refined docking outcome UX

• more polished review and queueing controls

• improved wet-list handoff support

Scientific Roadmap

On the science side, the roadmap continues toward:

• deeper entropy-aware lead discovery

• broader target support

• expanded IC₅₀ and assay-facing interpretation layers

• more advanced structural forensics

• richer scaffold-family analysis

• stronger post-docking AI interpretation layers

• future validation and benchmarking workflows

Platform Roadmap

At the platform level, I also see a path toward:

• citizen-scientist participation

• distributed simulation workflows

• selective local/cloud hybrid execution

• enterprise and lab-specific deployment patterns

• richer explainability and reproducibility features

• later expansion into adjacent discovery stacks built on the same foundation

Why I Built It

I built QuantumCURE Pro™ because too much early-stage drug discovery remains expensive, fragmented, and inaccessible to people who actually have ideas. I wanted to build a system that gives serious users a real workflow, not just a login screen and a score table. I wanted a platform that can prepare targets, run large campaigns, track entropy provenance, explain outcomes, shape batches before launch, and help build a defensible shortlist that can eventually matter in the real world.

QuantumCURE Pro™ is the result of that effort. It is being built deliberately, layer by layer, from Oklahoma City, with the goal of making serious discovery infrastructure available to more than just the largest institutions.

 

Closing

QuantumCURE Pro™ is not just a docking page. It is becoming a structured discovery factory.

It prepares proteins. It processes ligands. It executes docking campaigns. It tracks entropy. It scores and interprets results. It helps build shortlists, wet lists, and stronger decision pathways. And now, increasingly, it helps the user make better choices before the docking engine ever starts.

That is the direction of the platform, and that is the direction I am continuing to build.

​

​

​

​

​